Mutation Analysis of the Rearranged Immunoglobulin Heavy Chain Genes of Marginal Zone Cell Lymphomas Indicates an Origin From Different Marginal Zone B.

Slides:



Advertisements
Similar presentations
Lymphoma dissemination: the other face of lymphocyte homing by Steven T. Pals, David J. J. de Gorter, and Marcel Spaargaren Blood Volume 110(9):
Advertisements

Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations by Susan Price, Pamela A. Shaw, Amy Seitz, Gyan Joshi, Joie.
Investigating a New Methodology for the Detection of Low Frequency 17p Deleted Clones in Chronic Lymphocytic Leukaemia (CLL): Impact on Prognostic Outcome.
by Elaine S. Jaffe, Nancy Lee Harris, Harald Stein, and Peter G
Constitutive NF-κB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B- cell lymphomas by Lingchen Fu, Yen-Chiu Lin-Lee,
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
Immunoglobulin Gene Mutations and Frequent Use of VH1-69 and VH4-34 Segments in Hepatitis C Virus-Positive and Hepatitis C Virus-Negative Nodal Marginal.
The Prognostic Value Of Dynamic Monitoring C-Reactive Protein (CRP) Serum Levels In NK/T-Cell Lymphoma by Bing Bai, Qi-chun Cai, Xiao-Xiao Wang, Qingqing.
The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection by.
Do HSCs divide asymmetrically?
by Robert F. Todd, Scott D. Gitlin, Linda J. Burns, and
Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene by A.
TCR-MHC-peptide(s): in vivo veritas
Minimal Residual Disease Measurement By Deep Sequencing Reflects Changes In Disease Load During Therapy In Diffuse Large B Cell Lymphoma Patients by Nina.
by Dörte Bechtel, Julia Kurth, Claus Unkel, and Ralf Küppers
Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center.
Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency.
Analysis of expressed immunoglobulin heavy chain genes in familial B-CLL by Akira Sakai, Gerald E. Marti, Neil Caporaso, Stefania Pittaluga, Jeffrey W.
by David W. Bahler, John A. Miklos, and Steven H. Swerdlow
Idiotype Vaccination in Human Myeloma: Generation of Tumor-Specific Immune Responses After High-Dose Chemotherapy by Massimo Massaia, Paolo Borrione, Silvano.
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma by Lotta.
CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood by Mohamed F. Elshal,
Early Onset of Immunoglobulin Heavy Chain Gene Rearrangements in Normal Human Bone Marrow CD34+ Cells by Frédéric Davi, Ahmad Faili, Catherine Gritti,
Tax fingerprint in adult T-cell leukemia
Nonmyeloablative conditioning for relapsed follicular lymphoma
Mutagenic potential of temozolomide in bone marrow cells in vivo
SOX11 holds mantle cell lymphoma’s key to home
Fusion genes in cord blood
Adam Bagg  The Journal of Molecular Diagnostics 
Detection of Clonally Restricted Immunoglobulin Heavy Chain Gene Rearrangements in Normal and Lesional Skin  Minakshi Nihal, Debra Mikkola, Gary S. Wood 
What is a true ALCL? by Wolfram Klapper Blood Volume 124(9):
In situ identification of allospecific B cells using pentamers
High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric.
Tiago R. Matos, Menno A. de Rie, Marcel B.M. Teunissen 
by Clemens B. Caspar, Shoshana Levy, and Ronald Levy
by Lewis Hsu, Bhalchandra Diwan, Jerrold M. Ward, and Constance T
Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell.
VWF sequence variants: innocent until proven guilty
by Nelson Leung, Samih H. Nasr, and Sanjeev Sethi
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
by Christian H. Ottensmeier, and Freda K. Stevenson
IgA and IgM VH repertoires in human colon: Evidence for clonally expanded B cells that are widely disseminated  Wolfgang Holtmeier, Andreas Hennemann,
Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia by Manuela.
BCL-6 Protein Expression in Human Peripheral T-Cell Neoplasms Is Restricted to CD30+ Anaplastic Large-Cell Lymphomas by Antonino Carbone, Annunziata Gloghini,
Analysis of clonotypic switch junctions reveals multiple myeloma originates from a single class switch event with ongoing mutation in the isotype-switched.
Latest lymphoma classification is skin deep
Lymphoma spread? Target CD47-SIRPα!
How I treat refractory CLL
Expression of the Human Immunodeficiency Virus-Tat Gene in Lymphoid Tissues of Transgenic Mice Is Associated With B-Cell Lymphoma by Ramendra K. Kundu,
by George Z. Rassidakis, Mauricio P. Oyarzo, and L. Jeffrey Medeiros
ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase.
Deficiency of somatic hypermutation of the antibody light chain is associated with increased frequency of severe respiratory tract infection in common.
Anergy: the CLL cell limbo
HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8–positive plasmablastic lymphoma by Nicolas Dupin, Tim L.
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
Immunoglobulin Heavy Chain Gene Analysis in Lymphomas
CapTCR-seq: hybrid capture for T-cell receptor repertoire profiling
Primary Cutaneous Follicle Center Cell Lymphomas and Large B Cell Lymphomas of the Leg Descend from Germinal Center Cells. A Single Cell Polymerase Chain.
Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.
Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.
Resistance mechanism for ibrutinib in marginal zone lymphoma
Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity  Gertjan.
Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.
by Victor A. Chow, Mazyar Shadman, and Ajay K. Gopal
Optimizing therapy for nodal marginal zone lymphoma
Outcomes in patients with PTCL
Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity  Gertjan.
Presentation transcript:

Mutation Analysis of the Rearranged Immunoglobulin Heavy Chain Genes of Marginal Zone Cell Lymphomas Indicates an Origin From Different Marginal Zone B Lymphocyte Subsets by A. Tierens, J. Delabie, S. Pittaluga, A. Driessen, and C. DeWolf-Peeters Blood Volume 91(7):2381-2386 April 1, 1998 ©1998 by American Society of Hematology

Deduced protein sequences of the rearranged V h genes of the cases of marginal zone lymphomas. Deduced protein sequences of the rearranged V h genes of the cases of marginal zone lymphomas. Lowercase, replacement mutations with regard to the germline sequences. FR, framework; CDR, complementarity determining region. CDR regions are underlined. A. Tierens et al. Blood 1998;91:2381-2386 ©1998 by American Society of Hematology